Tetratherix Limited (ASX:TTX)

Australia flag Australia · Delayed Price · Currency is AUD
3.880
-0.090 (-2.27%)
At close: Mar 6, 2026
16.87%
Market Cap 196.97M
Revenue (ttm) 2.00M
Net Income (ttm) -11.97M
Shares Out 50.77M
EPS (ttm) -0.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,759
Average Volume 4,722
Open 3.990
Previous Close 3.970
Day's Range 3.850 - 3.990
52-Week Range 2.880 - 5.600
Beta n/a
RSI 52.49
Earnings Date May 22, 2026

About Tetratherix

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 15
Stock Exchange Australian Securities Exchange
Ticker Symbol TTX
Full Company Profile

Financial Performance

In fiscal year 2025, Tetratherix's revenue was 1.05 million, an increase of 21.88% compared to the previous year's 863,651. Losses were -9.43 million, 269.1% more than in 2024.

Financial Statements

News

There is no news available yet.